Systematic review of efficacy and safety of shorter regimens for drug-resistant tuberculosis (DR-TB) in children
Introduction: Recent years have witnessed the emergence of antimicrobial-resistant strains of Mycobacterium tuberculosis, resulting in drug-resistant tuberculosis (DR-TB). DR-TB is difficult to treat, necessitating prolonged therapy with multiple medications. However, attempts have been made to shor...
Saved in:
Main Authors: | Lovely Jain (Author), Meenakshi Malik (Author), Kulbir Kaur (Author), Sarita Dogra (Author), Abhishek Purohit (Author), Meenakshi Sachdeva (Author), Monica Chaudhry (Author), Pranita Pradhan (Author), Joseph L. Mathew (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost of digital technologies and family-observed DOT for a shorter MDR-TB regimen: a modelling study in Ethiopia, India and Uganda
by: Laura Rosu, et al.
Published: (2023) -
Comparative effectiveness of individualized longer and standardized shorter regimens in the treatment of multidrug resistant tuberculosis in a high burden country
by: Abdul Wahid, et al.
Published: (2022) -
The contribution of drug import to the cost of tuberculosis treatment: A cost analysis of longer, shorter, and short drug regimens for Karakalpakstan, Uzbekistan
by: Stefan Kohler, et al.
Published: (2022) -
The contribution of drug import to the cost of tuberculosis treatment: A cost analysis of longer, shorter, and short drug regimens for Karakalpakstan, Uzbekistan.
by: Stefan Kohler, et al.
Published: (2022) -
Correction: The contribution of drug import to the cost of tuberculosis treatment: A cost analysis of longer, shorter, and short drug regimens for Karakalpakstan, Uzbekistan.
by: Stefan Kohler, et al.
Published: (2024)